The University of Texas Health Science Center at Houston Pandemic Influenza Response Matrix, May 2017 WHO Phase CDC Intervals UTHealth EMP Status Additional Notes Inter-pandemic Phase (Phase 1-2): Period Investigation No actions necessary between influenza pandemics Pandemic Alert Phase (Phase 3-4): Investigation and Preparation for Influenza caused by a new subtype has communication support of UTHealth been identified in humans. EMP Maximum Readiness as outlined Pandemic Phase (Phase 5-6): Global Recognition Level 3 of the UTHealth spread of human influenza cause by a new Initiation EMP in Annex D of EMP subtype. Acceleration All departments who UTHealth will stay abreast of the Increased and sustained transmission in Deceleration maintain during recommendations from the CDC the US. the controlled access and modify current matrix as period must provide a necessary to supplement this critical employee list plan to the IC. Transition Phase: Reduction in global risk, Preparation UTHealth will follow all reduction in response activities, recommendations from CDC progression toward recovery actions specific to or regional situation and modify current matrix as necessary. UTHealth will stay abreast of Recovery: Local Health Departments lift restrictions based on 2 incubation periods the recommendations from the with no new cases; Return to CDC and modify current matrix Phase as necessary WHO Phase 1-2 WHO Phase 3 WHO Phase 4 WHO Phase 5 WHO Phase 6 Transition and Recovery Inter-Pandemic Pandemic Alert Pandemic Alert Pandemic Phase Pandemic Phase
The University of Texas Health Science Center at Houston Pandemic Influenza Response Matrix, May 2017 WHO Phase CDC Intervals UTHealth EMP Status Additional Notes Inter-pandemic Phase (Phase 1-2): Period between influenza pandemics Investigation No actions necessary Pandemic Alert Phase (Phase 3-4): Influenza caused by a new subtype has been identified in humans. Investigation and communication Preparation for support of UTHealth EMP Pandemic Phase (Phase 5-6): Global spread of human influenza cause by a new subtype. Increased and sustained transmission in the US. Recognition Initiation Acceleration Deceleration Level 3 of the UTHealth EMP All departments who maintain during the controlled access period must provide a critical employee list to the IC. Maximum Readiness as outlined in Annex D of EMP UTHealth will stay abreast of the recommendations from the CDC and modify current matrix as necessary to supplement this plan Transition Phase: Reduction in global risk, reduction in response activities, progression toward recovery actions Preparation UTHealth will follow all recommendations from CDC specific to or regional situation and modify current matrix as necessary. Recovery: Local Health Departments lift restrictions based on 2 incubation periods with no new cases; Return to Phase UTHealth will stay abreast of the recommendations from the CDC and modify current matrix as necessary WHO Phase 1-2 Inter-Pandemic WHO Phase 3 Pandemic Alert WHO Phase 4 Pandemic Alert WHO Phase 5 Pandemic Phase WHO Phase 6 Pandemic Phase Transition and Recovery
EMP%20for%202018%20(Public%20Version)%20Revised%2010.21.2018.docx